603233.SH
大参林
SSE · Healthcare · Biotechnology · CN
CNY 17.36
−1.70%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
14.6x
EV/EBITDA
7.7x
Market Cap
CNY 19.77B
MomentumView details →
1D Return
−1.70%
YTD Return
+6.64%
RSI (14)
57.0
ValuationView details →
P/E (Fwd)
14.6x
EV/EBITDA
7.7x
Market Cap
CNY 19.77B
RSI (14)
57.0
MomentumView details →
1D Return
−1.70%
YTD Return
+6.64%
Similar companies
Latest newsMore news →
Dashenlin's board proposed a cash dividend of 0.41 yuan per share (including tax) for the first half of 2026.11d agoDashenlin announced its first-half 2026 results: revenue of 13.991 billion yuan, up 3.46% year-on-year; net profit attributable to shareholders of 927 million yuan, up 16.10% year-on-year.11d ago